Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 20,000 APGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 20,000 | n/a |
| Jul 22, 2026 | Freenome, Inc. (FRNM) | Conversion | 30,000 | n/a |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 7,657 | n/a |
| May 29, 2026 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 8,026 | n/a |
| Jan 10, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 3,400 | n/a |
| Aug 11, 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Exercise/Conversion | 30,000 | n/a |
| Jun 21, 2025 | Apogee Therapeutics, Inc. (APGE) | Grant/Award | 14,461 | n/a |
| Jun 2, 2025 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 25,000 | n/a |
| Jan 8, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 6,960 | n/a |
| Dec 16, 2024 | Apogee Therapeutics, Inc. (APGE) | Purchase | 7,500 | $367.6K |